Benjamin Zeskind Insider Trades & Stock Holdings

PRESIDENT AND CEO · Immuneering Corporation · Latest filing Jun 23, 2026

Benjamin Zeskind, PRESIDENT AND CEO at Immuneering Corporation has 1 Form 4 trade on file since Jun 23, 2026. Open-market activity: 1 purchase ($10.94K) and 0 sales ($0), net +$10.94K. Latest filing: acquired 2.40K shares of $IMRX on Jun 23, 2026 at $4.56.

Trades on file

1

Open-market bought

$10.94K

Open-market sold

$0

Net open-market

+$10.94K

Latest filing

Jun 23, 2026

All insider trades by Benjamin Zeskind

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 23, 2026	$IMRX	Buy (Open-market buy)	2.40K	$4.56	$10.94K						PRESIDENT AND CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Benjamin Zeskind traded

• $IMRX

Frequently asked questions

Has Benjamin Zeskind been buying or selling stock?

Benjamin Zeskind has 1 open-market purchase and 0 open-market sales on file, net +$10.94K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Benjamin Zeskind's latest insider trade?

acquired 2.40K shares of $IMRX on Jun 23, 2026 at $4.56.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.